Lund Melanoma Study Group
31 – 40 of 245
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Risk factors and diagnostic tools in the skin cancer era
(2024) In Lund University, Faculty of Medicine Doctoral Dissertation Series
- Thesis › Doctoral thesis (compilation)
-
Mark
High Caveolin-1 mRNA expression in triple-negative breast cancer is associated with an aggressive tumor microenvironment, chemoresistance, and poor clinical outcome
Godina, Christopher LU
; Khazaei, Somayeh
LU
; Belting, Mattias
LU
; Vallon-Christersson, Johan
LU
; Nodin, Björn
LU
; Jirström, Karin
LU
; Isaksson, Karolin
LU
; Bosch, Ana
LU
and Jernström, Helena
LU
(2024)
In PLoS ONE
19(7).
p.1-21
- Contribution to journal › Article
-
Mark
Time trends of the association of body mass index with mortality in 3.5 million young Swedish adults
Mboya, Innocent B LU
; Fritz, Josef
LU
; da Silva, Marisa
LU
; Sun, Ming
LU
; Wahlström, Jens
; Magnusson, Patrik K E
; Sandin, Sven
; Yin, Weiyao
; Söderberg, Stefan
and Pedersen, Nancy L
, et al.
(2024)
In Annals of Epidemiology
97.
p.23-32
- Contribution to journal › Article
-
Mark
Cohort profile : The Obesity and Disease Development Sweden (ODDS) study, a pooled cohort
da Silva, Marisa LU
; Fritz, Josef
LU
; Mboya, Innocent B
LU
; Sun, Ming
LU
; Wahlström, Jens
; van Guelpen, Bethany
; Michaëlsson, Karl
; Magnusson, Patrik K E
; Melander, Olle
LU
and Sandin, Sven
, et al.
(2024)
In BMJ Open
14(7).
- Contribution to journal › Article
-
Mark
Tumour immune characterisation of primary triple-negative breast cancer using automated image quantification of immunohistochemistry-stained immune cells
Roostee, Suze LU
; Ehinger, Daniel
LU
; Jönsson, Mats
LU
; Phung, Bengt
LU
; Jönsson, Göran
LU
; Sjödahl, Gottfrid
LU
; Staaf, Johan
LU
and Aine, Mattias
LU
(2024)
In Scientific Reports
14(1).
- Contribution to journal › Article
- 2023
-
Mark
Phase II LEAP-004 Study of Lenvatinib Plus Pembrolizumab for Melanoma with Confirmed Progression on a Programmed Cell Death Protein-1 or Programmed Death Ligand 1 Inhibitor Given as Monotherapy or in Combination
Arance, Ana ; De La Cruz-Merino, Luis ; Petrella, Teresa M. ; Jamal, Rahima ; Ny, Lars ; Carneiro, Ana LU
; Berrocal, Alfonso
; Márquez-Rodas, Ivan
; Spreafico, Anna
and Atkinson, Victoria
, et al.
(2023)
In Journal of Clinical Oncology
41(1).
p.75-85
- Contribution to journal › Article
-
Mark
ASO Visual Abstract : Prognostic Significance of Sentinel Lymph Node Status in Thick Primary Melanomas (> 4 mm)
Holmberg, Carl-Jacob ; Mikiver, Rasmus ; Isaksson, Karolin LU ; Ingvar, Christian LU ; Moncrieff, Marc ; Nielsen, Kari LU
; Ny, Lars
; Lyth, Johan
and Olofsson Bagge, Roger
LU
(2023)
In Annals of Surgical Oncology
30(13).
p.8034-8035
- Contribution to journal › Published meeting abstract
-
Mark
Prognostic Significance of Sentinel Lymph Node Status in Thick Primary Melanomas (> 4 mm)
Holmberg, Carl-Jacob ; Mikiver, Rasmus ; Isaksson, Karolin LU ; Ingvar, Christian LU ; Moncrieff, Marc ; Nielsen, Kari LU
; Ny, Lars
; Lyth, Johan
and Olofsson Bagge, Roger
LU
(2023)
In Annals of Surgical Oncology
30(13).
p.8026-8033
- Contribution to journal › Article
-
Mark
Can active sun exposure decrease the risk of giant cell arteritis and polymyalgia rheumatica in women?
Gisslander, Karl LU
; de Boer, Raïssa
LU
; Ingvar, Christian
LU
; Turesson, Carl
LU
; Isaksson, Karolin
LU
; Jayne, David
and Mohammad, Aladdin
LU
(2023)
In Rheumatology Advances in Practice
7(3).
- Contribution to journal › Article
-
Mark
Survival in patients diagnosed with melanoma in situ compared to the general population. A Swedish population-based matched cohort study
- Contribution to journal › Article